PND21 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB AS PREVENTIVE TREATMENT IN CHRONIC AND EPISODIC MIGRAINE
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1294
https://www.valueinhealthjournal.com/article/S1098-3015(19)31486-X/fulltext
Title :
PND21 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB AS PREVENTIVE TREATMENT IN CHRONIC AND EPISODIC MIGRAINE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31486-X&doi=10.1016/j.jval.2019.04.1294
First page :
Section Title :
Open access? :
No
Section Order :
10797